120 related articles for article (PubMed ID: 3052183)
1. Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound.
Bernardi D; Bartoli P; Ferreri A; Geri AB; Ieri A
Angiology; 1988 Nov; 39(11):942-52. PubMed ID: 3052183
[TBL] [Abstract][Full Text] [Related]
2. Ticlopidine in the treatment of peripheral occlusive arterial disease.
Arcan JC; Panak E
Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
[No Abstract] [Full Text] [Related]
3. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
[TBL] [Abstract][Full Text] [Related]
4. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
Lindgärde F; Jelnes R; Björkman H; Adielsson G; Kjellström T; Palmquist I; Stavenow L
Circulation; 1989 Dec; 80(6):1549-56. PubMed ID: 2688972
[TBL] [Abstract][Full Text] [Related]
5. Comparison of standard one-minute treadmill exercise and strandness test (absolute walking distance) in relation to site of lesion, walking distance, and diastolic blood flow velocity (Doppler curves).
Fabry R; Dubost JJ; Pochon P; Duchêne-Marullaz P
Angiology; 1990 Oct; 41(10):869-76. PubMed ID: 2221465
[TBL] [Abstract][Full Text] [Related]
6. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
7. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Ehrly AM; Saeger-Lorenz K
Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
[TBL] [Abstract][Full Text] [Related]
8. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
9. Doppler techniques for lower extremity arterial diagnosis.
Zierler RE
Herz; 1989 Apr; 14(2):126-33. PubMed ID: 2656456
[TBL] [Abstract][Full Text] [Related]
10. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
11. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
[TBL] [Abstract][Full Text] [Related]
12. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
[TBL] [Abstract][Full Text] [Related]
13. Effects of naftidrofuryl in patients with intermittent claudication.
Karnik R; Valentin A; Stöllberger C; Slany J
Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of isoxsuprine in patients with intermittent claudication.
Skotnicki SH; van Gaal G; Wijn PF
Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
16. Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease.
Liu Y; Opitz-Gress A; Rott A; Liewald F; Sunder-Plassmann L; Lehmann M; Stauch M; Steinacker JM
Vasc Med; 1997; 2(1):13-8. PubMed ID: 9546944
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
[TBL] [Abstract][Full Text] [Related]
18. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
[TBL] [Abstract][Full Text] [Related]
19. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
20. Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudication.
Trainor FS; Phillips RE; Michie DD; Zellner SR; Hogan L; Chubb JM
Angiology; 1986 May; 37(5):343-51. PubMed ID: 3521401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
